An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the ...

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.

Pfizer said on Tuesday it entered into an exclusive licensing agreement with YaoPharma, a subsidiary of China's Shanghai ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...

Giredestrant lowered the risk of disease recurrence or death by 30%, compared with standard-of-care endocrine therapy, according to the company.

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...

Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

A study carried out by the University of Bonn and the University Hospital Bonn throws light on how an important receptor can be inhibited.